Albert A. Minnick

639 total citations
14 papers, 517 citations indexed

About

Albert A. Minnick is a scholar working on Molecular Biology, Organic Chemistry and Molecular Medicine. According to data from OpenAlex, Albert A. Minnick has authored 14 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Molecular Medicine. Recurrent topics in Albert A. Minnick's work include Antibiotic Resistance in Bacteria (5 papers), Ubiquitin and proteasome pathways (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Albert A. Minnick is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Ubiquitin and proteasome pathways (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Albert A. Minnick collaborates with scholars based in United States, Canada and Germany. Albert A. Minnick's co-authors include E. Kurt Dolence, Marvin J. Miller, J Andrew McKee, George L. Kenyon, Lee M. Greenberger, Marvin J. Miller, François Malouin, Alexey Ruzin, Guy Singh and Alan G. Sutherland and has published in prestigious journals such as Biochemistry, Cancer Research and Analytical Biochemistry.

In The Last Decade

Albert A. Minnick

13 papers receiving 489 citations

Peers

Countries citing papers authored by Albert A. Minnick

Since Specialization

Citations

This map shows the geographic impact of Albert A. Minnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert A. Minnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert A. Minnick more than expected).

Fields of papers citing papers by Albert A. Minnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert A. Minnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert A. Minnick. The network helps show where Albert A. Minnick may publish in the future.

Co-authorship network of co-authors of Albert A. Minnick

This figure shows the co-authorship network connecting the top 25 collaborators of Albert A. Minnick. A scholar is included among the top collaborators of Albert A. Minnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert A. Minnick. Albert A. Minnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents 2009 ·BioMetals ·Marvin J. Miller, Helen He Zhu, (unknown), Chunrui Wu, Andrew J. Walz, (unknown), (unknown), Garrett C. Moraski, Albert A. Minnick, (unknown), Jingdan Hu, (unknown), E. Kurt Dolence, Li Dong, Scott G. Franzblau, François Malouin, Ute Möllmann	77
2	Two Photoaffinity Analogues of the Tripeptide, Hemiasterlin, Exclusively Label α-Tubulin 2005 ·Biochemistry ·Maria Nunes, Joshua A. Kaplan, Joseph L. Wooters, Malathi Hari, Albert A. Minnick, (unknown), Celine Shi, Sylvia Musto, Carl F. Beyer, Girija Krishnamurthy, Yongchang Qiu, Frank Loganzo, Semiramis Ayral‐Kaloustian, Arie Zask, Lee M. Greenberger	22
3	Hemiasterlin analogs exclusively label α-tubulin at the interdimer region and specifically block subtilisin digestion of α-tubulin 2004 ·Cancer Research ·Malathi Hari, Maria Nunes, Arie Zask, Joshua A. Kaplan, Joseph L. Wooters, Albert A. Minnick, (unknown), Sylvia Musto, Carl F. Beyer, Girija Krishnamurthy, Yongchang Qiu, Frank Loganzo, Semiramis Ayral‐Kaloustian, Lee M. Greenberger	1
4	Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin. 2004 ·PubMed ·Frank Loganzo, Malathi Hari, Tami Annable, Xingzhi Tan, (unknown), Sylvia Musto, Arie Zask, Joshua A. Kaplan, Albert A. Minnick, (unknown), Semiramis Ayral‐Kaloustian, Marianne S. Poruchynsky, Tito Fojo, Lee M. Greenberger	25
5	Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in α-tubulin 2004 ·Molecular Cancer Therapeutics ·Frank Loganzo, Malathi Hari, Tami Annable, Xingzhi Tan, (unknown), Sylvia Musto, Arie Zask, Joshua A. Kaplan, Albert A. Minnick, (unknown), Semiramis Ayral‐Kaloustian, Marianne S. Poruchynsky, Tito Fojo, Lee M. Greenberger	24
6	Mechanism of Action of the Mannopeptimycins, a Novel Class of Glycopeptide Antibiotics Active against Vancomycin-Resistant Gram-Positive Bacteria 2004 ·Antimicrobial Agents and Chemotherapy ·Alexey Ruzin, Guy Singh, Anatoly Severin, Youjun Yang, Russell G. Dushin, Alan G. Sutherland, Albert A. Minnick, Michael Greenstein, (unknown), David M. Shlaes, Patricia A. Bradford	74
7	Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785) 1999 ·Biochemical Pharmacology ·Carolyn Discafani, Marion L. Carroll, M. Brawner Floyd, Irwin Hollander, Zaheed Husain, Bernard D. Johnson, Douglas B. Kitchen, (unknown), Madhu S. Malo, Albert A. Minnick, Ramaswamy Nilakantan, Ru Shen, (unknown), Allan Wissner, Lee M. Greenberger	84
8	Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria 1992 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), Thalia I. Nicas, Thomas Parr, Albert A. Minnick, E. Kurt Dolence, J Andrew McKee, Marvin J. Miller, Michel Lavoie, François Malouin	47
9	Iron transport-mediated antibacterial activity of and development of resistance to hydroxamate and catechol siderophore-carbacephalosporin conjugates 1992 ·Antimicrobial Agents and Chemotherapy ·Albert A. Minnick, J Andrew McKee, E. Kurt Dolence, Marvin J. Miller	29
10	Bioassay for siderophore utilization by Candida albicans 1991 ·Analytical Biochemistry ·Albert A. Minnick, (unknown), (unknown), E. Kurt Dolence, Marvin J. Miller	15
11	The design, synthesis and study of siderophore-antibiotic conjugates Siderophore mediated drug transport 1991 ·BioMetals ·Marvin J. Miller, (unknown), Albert A. Minnick, E. Kurt Dolence	25
12	Synthesis and siderophore and antibacterial activity of N5-acetyl-N5-hydroxyl-L-ornithine derived siderophore-.beta.-lactam conjugates: iron transport mediated drug delivery 1991 ·Journal of Medicinal Chemistry ·E. Kurt Dolence, Albert A. Minnick, (unknown), Marvin J. Miller, Shelley M. Payne	32
13	N5-Acetyl-N5-hydroxy-L-ornithine-derived siderophore-carbacephalosporin .beta.-lactam conjugates: iron transport mediated drug delivery 1990 ·Journal of Medicinal Chemistry ·E. Kurt Dolence, Albert A. Minnick, Marvin J. Miller	39
14	General synthetic approach to stable nitrogen analogs of S-adenosylmethionine 1988 ·The Journal of Organic Chemistry ·Albert A. Minnick, George L. Kenyon	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact